Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax

Br J Haematol. 2023 Nov;203(4):e98-e101. doi: 10.1111/bjh.19022. Epub 2023 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Consensus
  • Humans
  • Leukemia, Myeloid, Acute* / etiology
  • Sulfonamides / therapeutic use

Substances

  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides